Cargando…
miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma
Inactivation of human SET domain containing protein 2 (SETD2) is a common event in clear cell renal cell carcinoma (ccRCC). However, the mechanism underlying loss of SETD2 function, particularly the post-transcriptional regulatory mechanism, still remains unclear. In the present study, we found that...
Autores principales: | Xiang, Wei, He, Jun, Huang, Chao, Chen, Lejun, Tao, Dan, Wu, Xinchao, Wang, Miao, Luo, Gang, Xiao, Xingyuan, Zeng, Fuqing, Jiang, Guosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414173/ https://www.ncbi.nlm.nih.gov/pubmed/25714014 |
Ejemplares similares
-
PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth
por: Xiang, Wei, et al.
Publicado: (2016) -
Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma
por: Wang, Xingyuan, et al.
Publicado: (2022) -
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023) -
Circular RNA ITCH Is a Tumor Suppressor in Clear Cell Renal Cell Carcinoma Metastasis through miR-106b-5p/PDCD4 Axis
por: Gao, Ping, et al.
Publicado: (2021) -
Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma()
por: Li, Jun, et al.
Publicado: (2016)